NeuroSense Therapeutics Ltd (NRSN) Stock Price

1.0378 ▲ +0.0578 (+5.90%)
Open: 0.98 Vol: 130.7K Day's range: 0.93 - 1.04 May 01, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
NRSN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL BUY SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.97▼ 0.97▼ 0.97▼ 0.99▲ 1.02▲
MA10 0.97▼ 0.98▼ 0.98▼ 1.00▲ 1.06▼
MA20 0.99▼ 0.99▼ 0.99▼ 1.00▲ 1.11▼
MA50 1.02▼ 1.02▼ 1.00▼ 1.05▼ 1.07▼
MA100 1.01▼ 1.00▼ 1.03▼ 1.08▼ 1.09▼
MA200 1.05▼ 1.07▼ 1.07▼ 1.06▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.001▼ -0.003▼ -0.004▼ 0.003▲ -0.011▼
RSI 37.144▼ 39.256▼ 39.954▼ 53.560▲ 47.508▼
STOCH 14.301▼ 11.996▼ 11.810▼ 37.092     39.023    
WILL %R -94.655▼ -94.655▼ -94.655▼ -32.625     -56.457    
CCI -97.451     -105.866▼ -117.562▼ -17.626     -80.337    
Latest Filters Detected On NRSN
▲ RSI&VOL $NRSN RSI Cross Up and Volume Set Alert
RSI $NRSN RSI(14) Crossed Above 50 Set Alert
▲ MACD $NRSN MACD(12,26,9) Crossed Above Signal Line Set Alert
MA $NRSN Price Crossed Above MA(26) Set Alert
MA $NRSN Price Crossed Above MA(13) Set Alert
MA $NRSN Price Crossed Above MA(7) Set Alert
NeuroSense Therapeutics Ltd News
NeuroSense Therapeutics Announces Transformative Phase 2b MicroRNA Data, Highlighting PrimeC's Promise as a Disease-Modifying ALS Treatment
Wednesday, April 09, 2025 01:30 AM
CAMBRIDGE, Mass., April 9, 2025 /PRNewswire/ -- NeuroSense Therapeutics, Ltd. (NASDAQ: NRSN), a leading clinical-stage biotechnology company focused on developing treatments for severe ...
The Nasdaq Is Officially in a Bear Market. Here's Why History Says Investors Shouldn't Panic.
Tuesday, April 08, 2025 04:12 AM
The Nasdaq Composite (NASDAQINDEX: ^IXIC) is officially in a bear market. While it had been floating around in correction territory for a few weeks, it fell more than 20% below its all-time high ...
NeuroSense Therapeutics Reports 2024 Financial Results and Advances ALS Treatment
Monday, April 07, 2025 06:04 PM
Neurosense Therapeutics Ltd. ( (NRSN)) has provided an announcement. On April 7, 2025, NeuroSense Therapeutics announced its financial results for the year ending December 31, 2024, and provided ...
NRSN historical stock data
date open high low close volume
01/05/25 0.98 1.04 0.93 1.0378 130,698
30/04/25 0.96 1.00 0.95 0.98 53,685
29/04/25 0.9699 0.9699 0.96 0.96 39,883
28/04/25 0.9761 1.02 0.97 0.9787 119,836
25/04/25 1.00 1.0157 0.97 0.9999 70,729
24/04/25 1.02 1.02 0.96 1.00 119,543
23/04/25 1.04 1.04 0.95 0.9869 81,556
22/04/25 1.01 1.02 0.98 1.01 71,041
21/04/25 1.02 1.02 0.965 1.00 89,075
17/04/25 1.07 1.07 0.98 1.0333 134,261
Quote Details
52wk Low:0.512
52wk High:1.50
Vol:130.7K
Avg Vol(3m):2.1M
1Y Chng:-7.34%
1M Chng:-2.77%
Add to Watch List
More Information
Index US Composite
Market Cap. 23.48M